Aging – Page 2 – Waisman Center – UW–Madison

Alzheimer’s polygenic risk scores are associated with cognitive phenotypes in Down syndrome

Characterizing the emergence of amyloid and tau burden in Down syndrome

AT(N) biomarker profiles and Alzheimer’s disease symptomology in Down syndrome

Plasma NT1-tau and Aβ42 correlate with age and cognitive function in two large Down syndrome cohorts

Weight Loss and Alzheimer’s Disease in Down Syndrome

Mitochondrial regulator PGC-1a in neuronal metabolism and brain aging

Timing of Alzheimer’s Disease by Intellectual Disability Level in Down Syndrome

Mortality rate and age of death among Medicare-enrolled autistic older adults

Comparison of amyloid burden in individuals with Down syndrome versus autosomal dominant Alzheimer’s disease: a cross-sectional study

Associations between diffusion MRI microstructure and cerebrospinal fluid markers of Alzheimer’s disease pathology and neurodegeneration along the Alzheimer’s disease continuum